Change search
ReferencesLink to record
Permanent link

Direct link
Modifiable cardiovascular risk factors in patients with ankylosing spondylitis
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Reumatology. University Hospital, Umeå.ORCID iD: 0000-0001-7226-0969
Högskolan i Halmstad, Sektionen för hälsa och samhälle .
Umeå University, Faculty of Medicine, Department of Odontology, Cariology.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Reumatology.
2014 (English)In: Clinical Rheumatology, ISSN 0770-3198, E-ISSN 1434-9949, Vol. 33, no 1, 111-117 p.Article in journal (Refereed) Published
Abstract [en]

The aim of this study was to evaluate whether modifiable cardiovascular disease (CVD) risk factors, e.g. atherogenic blood lipids, hypertension and lifestyle-related factors such as smoking, diet and physical inactivity, differ among patients with ankylosing spondylitis (AS) in comparison to the general population. Eighty-eight patients diagnosed with AS were identified by analysis of the databases of a previous community intervention programme, the Västerbotten intervention programme. The patients were compared with 351 controls matched for age, sex and study period. These databases include the results of blood samples analysed for cholesterol, triglycerides and plasma glucose, as well as data on hypertension, height, weight, smoking and dietary habits and physical activity. No significant differences were found between patients and controls regarding hypertension, body mass index, physical activity, diet or smoking. Levels of serum triglycerides (p < 0.01) and cholesterol (p < 0.01) were significantly lower in the patient group. Among the patients, the level of triglycerides correlated inversely with the intake of total fat (r s = −0.25, p < 0.05), monounsaturated fats (r s = −0.29, p < 0.05) and positively correlated to the intake of carbohydrates (r s = 0.26, p < 0.05). These associations were not apparent among the controls. In the cohort of AS patients studied, no differences were found regarding the modifiable risk factors for CVD compared with the general population. Hence, the increased presence of CVD in patients with AS may be caused by other factors such as differences in metabolism and medication such as NSAID or the chronic low-grade inflammation present in the disease.

Place, publisher, year, edition, pages
Springer London, 2014. Vol. 33, no 1, 111-117 p.
Keyword [en]
Ankylosing spondylitis, Cardiovascular disease, Hypertension
National Category
Rheumatology and Autoimmunity
Research subject
Medicine, rheumatology
URN: urn:nbn:se:umu:diva-81648DOI: 10.1007/s10067-013-2410-4OAI: diva2:657412
Available from: 2013-10-18 Created: 2013-10-18 Last updated: 2014-02-17Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Sundström, BjörnJohansson, IngegerdWållberg Jonsson, Solveig
By organisation
In the same journal
Clinical Rheumatology
Rheumatology and Autoimmunity

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 85 hits
ReferencesLink to record
Permanent link

Direct link